ArticleBioscience2025
A new indicator for the Kunming-Montreal Global Biodiversity Framework: Capturing non-monetary benefit data from access and benefit-sharing agreements.
Article in Bioscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Repositioning of indigenous breeds in the pivot of climate crisis, food assurance, and biosecurity: genetic archive and evolutionary dynamics.Tropical animal health and production · 2026Review
- How can biological databases support the new UN mechanism for benefit-sharing from digital sequence information?Scientific data · 2026Article
- Reimagining plant science training in the era of generative artificial intelligence: a global perspective.The Plant cell · 2026Review
- The PABS system under the pandemic agreement: Current status, controversies in negotiations, and future trends.Biosafety and health · 2026Article
- An automated decision-making procedure for ranking and selecting species in biodiversity projects.npj biodiversity · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 2022 Kunming-Montreal Global Biodiversity Framework (KMGBF) moves international efforts to conserve biodiversity into a quantitative era. Fair and equitable benefit-sharing is one of the three objectives of the Convention on Biological Diversity, which means that to achieve the KMGBF, its parties will need to begin quantifying the benefits received from access and benefit-sharing (ABS). This mandate represents a big challenge as countries will need to begin to measure both monetary and non-monetary benefits from ABS agreements. Non-monetary benefits, in particular, can be more difficult to measure than monetary benefits, resulting in lower scientific understanding and integration of scientific results into national policy choices. In the present article, we propose a new methodology to deliver data to the KMGBF on non-monetary benefit-sharing indicators using scientific publications that cite ABS permits and put forth recommendations for improving the visibility of non-monetary benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.